Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
14.53
-0.37 (-2.48%)
May 29, 2026, 4:00 PM EDT - Market closed
Anika Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 116.26 | 112.82 | 119.91 | 120.79 | 113.83 | 147.79 | |
Revenue Growth (YoY) | 36.52% | -5.91% | -0.73% | 6.12% | -22.98% | 13.29% |
Cost of Revenue | 48.14 | 49.01 | 43.91 | 38.26 | 40.61 | 64.85 |
Gross Profit | 68.12 | 63.81 | 76 | 82.53 | 73.22 | 82.94 |
Selling, General & Admin | 53.95 | 49.09 | 55.56 | 59.93 | 51.23 | 74.1 |
Research & Development | 26.42 | 25.77 | 25.54 | 21.76 | 18.32 | 27.33 |
Other Operating Expenses | - | 0 | 0 | 0 | 0 | -21.1 |
Total Operating Expenses | 80.38 | 74.86 | 81.1 | 81.69 | 69.55 | 80.33 |
Operating Income | -12.26 | -11.05 | -5.1 | 0.84 | 3.67 | 2.62 |
Interest Income | 2 | 1.74 | 2.34 | 2.31 | 0.65 | -0.19 |
Total Non-Operating Income (Expense) | 2 | 1.74 | 2.34 | 2.31 | 0.65 | -0.19 |
Pretax Income | -10.26 | -9.31 | -2.76 | 3.16 | 4.32 | 2.43 |
Provision for Income Taxes | 0.82 | 0.67 | 6.06 | 6.6 | 2.12 | -1.71 |
Net Income | -11.06 | -10.88 | -56.39 | -82.67 | -14.86 | 4.13 |
Earnings From Discontinued Operations | 0.01 | -0.9 | -47.56 | -79.23 | -17.06 | - |
Net Income to Common | -11.06 | -10.88 | -56.39 | -82.67 | -14.86 | 4.13 |
Shares Outstanding (Basic) | 14 | 14 | 15 | 15 | 15 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 15 | 15 | 15 | 15 |
Shares Change (YoY) | -2.33% | -2.60% | 0.44% | -0.89% | 1.05% | 2.90% |
EPS (Basic) | -0.68 | -0.70 | -0.60 | -0.23 | 0.15 | 0.29 |
EPS (Diluted) | -0.69 | -0.70 | -0.60 | -0.23 | 0.15 | 0.28 |
EPS Growth | - | - | - | - | -46.43% | - |
Shares Outstanding | 13.36 | 13.89 | 14.42 | 14.66 | 14.63 | 14.44 |
Free Cash Flow | 1.04 | 4.36 | -2.33 | -7.22 | -3.08 | 3.25 |
Free Cash Flow Growth | -76.18% | - | - | - | - | -71.55% |
Free Cash Flow Per Share | 0.07 | 0.30 | -0.16 | -0.49 | -0.21 | 0.22 |
Gross Margin | 58.59% | 56.56% | 63.38% | 68.33% | 64.33% | 56.12% |
Operating Margin | -10.54% | -9.80% | -4.25% | 0.70% | 3.22% | 1.77% |
Profit Margin | -9.53% | -8.85% | -7.36% | -2.85% | 1.93% | 2.80% |
FCF Margin | 0.89% | 3.87% | -1.94% | -5.97% | -2.70% | 2.20% |
EBITDA | -6.71 | -5.32 | 3.02 | 15.06 | 18.16 | 23.4 |
EBITDA Margin | -5.77% | -4.72% | 2.52% | 12.47% | 15.95% | 15.83% |
EBIT | -12.26 | -11.05 | -5.1 | 0.84 | 3.67 | 2.62 |
EBIT Margin | -10.54% | -9.80% | -4.25% | 0.70% | 3.22% | 1.77% |
Effective Tax Rate | -7.97% | -7.22% | -219.39% | 208.97% | 49.12% | -70.33% |